Sanj K. Patel serves as Executive at SYNAGEVA BIOPHARMA CORP, where they oversee executive responsibilities. Since joining the company, Sanj K. Patel has executed 159 insider transactions totaling $63.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 31, 2012 involved selling 15,187 shares valued at $757.5K.
Sanj K. Patel currently holds 60,000 shares of SYNAGEVA BIOPHARMA CORP (GEVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanj K. Patel has been a net seller of GEVA stock. They have purchased $0 and sold $63.7M worth of shares.
Sanj K. Patel's most recent insider trade was on Aug 31, 2012, when they sold 15,187 shares at $49.88 per share.
Get notified when new Form 4 filings are submitted
| $0.95 |
| Discretionary |
| Jun 4, 2012 | GEVA | $723.8K | Sale | 20,866 | $34.69 | Discretionary |
| Jun 1, 2012 | GEVA | $332.1K | Sale | 9,234 | $35.96 | Discretionary |
| Jun 1, 2012 | GEVA | $710.4K | Sale | 19,900 | $35.70 | Discretionary |
| Jun 1, 2012 | GEVA | $8.8K | Option Exercise | 9,234 | $0.95 | Discretionary |
| Jun 1, 2012 | GEVA | $18.9K | Option Exercise | 19,900 | $0.95 | Discretionary |
| Mar 23, 2012 | GEVA | $47.5K | Option Exercise | 50,000 | $0.95 | Discretionary |
| Mar 23, 2012 | GEVA | $1.7M | Sale | 50,000 | $33.53 | Discretionary |